Lisata Therapeutics Terminates Kuva Labs Merger After Financing Failure; To Receive $2 Million FeeTradingView·Jul 24 at 11:23 AMLSTA-3.67%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 21 at 12:05 PMTELO+3.31%CPHI+5.83%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Jul 21 at 07:05 AMZYBT+9.92%IMNN+3.90%
Lisata Therapeutics, Kuva Labs extend merger agreement outside date to July 21PUBT·Jul 17 at 06:02 AMLSTA-3.67%
Pre-market hot trades in US stocks: Lisata Therapeutics pre-market down 13.24%; Applied Materials pre-market up 3.67%Price Alert·Jul 14 at 05:07 AMLSTA-3.67%AMAT+15.21%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Jul 9 at 04:05 PMBMGL-0.50%VRAX-4.95%
Lisata Therapeutics shares are trading higher. Kuva Labs' subsidiary has commenced the tender offer to purchase all issued and outstanding shares of Lisata Therapeutics.benzinga_article·Jun 10 at 09:20 AMLSTA-3.67%
Lisata Therapeutics deal delayed as buyer postpones planned June 1 tender offerTradingView·Jun 1 at 05:13 AMLSTA-3.67%
